Name | BIRT 377 |
---|---|
Synonyms |
(5R)-5-[(4-Bromophenyl)methyl]-3-(3,5-dichlorophenyl)-1,5-dimethyl-2,4-imidazolidinedione
2,4-Imidazolidinedione, 5-[(4-bromophenyl)methyl]-3-(3,5-dichlorophenyl)-1,5-dimethyl-, (5R)- (5R)-5-(4-Bromobenzyl)-3-(3,5-dichlorophenyl)-1,5-dimethyl-2,4-imidazolidinedione (5R)-5-(4-bromobenzyl)-3-(3,5-dichlorophenyl)-1,5-dimethylimidazolidine-2,4-dione |
Description | BIRT 377 is a potent amd orally bioavailable inhibitor of the interaction between intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1), with a Ki of 25.8 nM. BIRT 377 also inhibits the production of IL-2 in vivo. BIRT 377 can be used for researching inflammatory and immune disorders[1]. |
---|---|
Related Catalog | |
Target |
Ki: 25.8 nM (LFA-1)[1] |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 518.8±60.0 °C at 760 mmHg |
Molecular Formula | C18H15BrCl2N2O2 |
Molecular Weight | 442.13 |
Flash Point | 267.6±32.9 °C |
Exact Mass | 439.969391 |
LogP | 4.76 |
Vapour Pressure | 0.0±1.4 mmHg at 25°C |
Index of Refraction | 1.632 |